Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s ...
Headquartered in Marlborough, Massachusetts, Boston Scientific Corporation (BSX) is a global medical technology company that ...
Boston Scientific Corporation remains in focus after its latest business update highlighted broad operational growth, ...
While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation ...
MARLBOROUGH, Mass., Jan. 7, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) ...
The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for global neuromodulation devices. According to Grand View Research, the market ...
Medical device maker Boston Scientific said on Monday it had agreed to buy Axonics for $3.7 billion, gaining access to devices used to improve bladder function. The deal marks Boston Scientific's ...
* Sees Cosman Medical team and products will become part of Boston Scientific neuromodulation business * Expects net impact of this transaction on adjusted earnings per share to be break-even in 2016 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results